factual

Competitor safety data appears worse on the same target

Early data from competitor drugs on the same target show a large safety gap versus Argenx's drug, which Julia argues is a key differentiator.

factualpending

Speaker

Julia

Evidence Quote

“there is a massive difference. More importantly, it's on the safety”

Source

Argenx: Changing Lives with Llamas— Business Breakdowns
Created: 11/17/2026, 3:39:21 AM

Your notes

Loading notes...